ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Endpoints News LGBTQ+ Biopharma Leaders '23
Find more about the scientists, executives, founders and academics who are leading the way for LGBTQ+ inclusion in the drug development industry.
Disease surveillance and vaccine development
In this article in Life Science Review, Dinah Knotts outlines how disease surveillance can play an important role in emerging infectious disease early.
Realising the benefits of bringing the trial to the patient
This article outlines how in-home services are being baked into trials because of their value in supporting patient-centric trials with decentralised components.
The most explored endpoints in decentralised clinical trials
Harpreet Gill and Keith Thomas contribute to this article that investigates decentralisation from the perspective of trial endpoints or outcome measures.
Transfer of marketing authorisation
In this interview, Alma Salibasic, discusses the role of a Marketing Authorisation Transfer during mergers and acquisitions in the bio pharma industry.
Interview: Everything you need to know about becoming a clinical research associate
In this interview, Sara Brannon, Director of Quality and Training Development at ICON, shares the approach to recruiting clinical research associates.
Challenges of expanding CAR-T Cell Therapy into solid tumors
Read more about the challenges in developing CAR-T therapies for solid tumors in this article.
Clinical Data Management
In this article, Michael Phillips, discusses the ways in which machine learning can replace or augment traditional data review approaches.
The human condition
In this article, Patricia Murphy discusses how the industry needs to make rare disease clinical trials more human.
Making accessibility strategy part of your rare disease trial planning
In this article, Laura Iliescu, discusses strategies to improve inclusion of people with disabilities in rare disease trials.